← Evidence map

ArticleClinical and molecular hepatology2026

Optimized MASH treatment eligibility cutoffs for MRE-measured liver stiffness and proton density fat fraction.

Nana Owusu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 41360082